Literature DB >> 11702370

A tool for assessing the usefulness of prevalence studies done for surveillance purposes: the example of hypertension.

L C Silva1, P Ordúñez, M Paz Rodríguez, S Robles.   

Abstract

Every year dozens of cross-sectional studies are carried out that estimate the prevalence of risk factors for chronic noncommunicable diseases. Given that, there is potentially a large amount of information that could be extremely useful for risk factor surveillance. However, there are good reasons to question the methodological rigor and the reliability of the results coming from many of these studies. The potential benefits of the data are curtailed by the studies' shortcomings, in part often because there is no clear and explicit methodological information providing the details needed to assess the procedures that were actually used, as well as a failure to apply a uniform methodology that would allow comparisons over time or across studies. This paper is intended to be both a didactic and practical tool. It describes the construction of an instrument for assessing the usefulness of prevalence studies done within the context of surveillance activities, using the example of hypertension. The paper discusses and illustrates the most common pitfalls found with prevalence studies, and it also offers methodological standards that can guide future prevalence studies as well as stimulate future research efforts in this area.

Entities:  

Mesh:

Year:  2001        PMID: 11702370     DOI: 10.1590/s1020-49892001000900002

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  7 in total

1.  A new instrument for assessing the quality of studies on prevalence.

Authors:  Nikolaos Nikitas Giannakopoulos; Peter Rammelsberg; Lydia Eberhard; Marc Schmitter
Journal:  Clin Oral Investig       Date:  2011-05-19       Impact factor: 3.573

2.  Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee.

Authors:  Marianne E Gee; Norm Campbell; Nizal Sarrafzadegan; Tazeen Jafar; Tej K Khalsa; Birinder Mangat; Neil Poulter; Dorairaj Prabhakaran; Sandor Sonkodi; Paul K Whelton; Mark Woodward; Xin-Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-08-26       Impact factor: 3.738

3.  Birth prevalence of phenylalanine hydroxylase deficiency: a systematic literature review and meta-analysis.

Authors:  Pamela K Foreman; Andrea V Margulis; Kimberly Alexander; Renee Shediac; Brian Calingaert; Abenah Harding; Manel Pladevall-Vila; Sarah Landis
Journal:  Orphanet J Rare Dis       Date:  2021-06-03       Impact factor: 4.123

4.  Prevalence of hypertension and associated factors in an indigenous community of central Brazil: a population-based study.

Authors:  Geraldo F Oliveira; Teresinha R R Oliveira; Adauto T Ikejiri; Mariela P Andraus; Tais F Galvao; Marcus T Silva; Maurício G Pereira
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

5.  Prevalence of psychological symptoms among adults with sickle cell disease in Korle-Bu Teaching Hospital, Ghana.

Authors:  Michael Tetteh Anim; Joseph Osafo; Felix Yirdong
Journal:  BMC Psychol       Date:  2016-11-10

6.  Hypertension Prevention and Control in Latin America and the Caribbean.

Authors:  Pedro Ordunez; Ramon Martinez; Mark L Niebylski; Norm R Campbell
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-28       Impact factor: 3.738

Review 7.  Chlamydia prevalence in the general population: is there a sex difference? a systematic review.

Authors:  Patrick W Dielissen; Doreth A M Teunissen; Antoine L M Lagro-Janssen
Journal:  BMC Infect Dis       Date:  2013-11-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.